OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Alzheimers Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer’s Disease Spectrum	147
Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	135
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	133
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	104
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	92
BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols	91
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	82
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	78
White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults	73
GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer’s Disease	71
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	69
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	68
A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan	65
A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders	60
Joint Computational/Cell-Based Approach for Screening Inhibitors of Tau Oligomerization: A Proof-of-Concept Study	56
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	55
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	55
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	54
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	53
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	52
A Mixed-Methods Study of the Impact of Mild Cognitive Impairment Diagnosis on Patient and Care Partner Perception of Health Risks	52
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	51
Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging	50
Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study	48
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	47

Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	47
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	47
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	47
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	46
Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer’s Disease	45
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	45
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	44
Methylcobalamin Alleviates Neuronal Apoptosis and Cognitive Decline Induced by PM2.5 Exposure in Mice	43
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	43
Implication of Small Vessel Disease MRI Markers in Alzheimer’s Disease and Lewy Body Disease1	42
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	42
Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer’s Disease Rat Model	42
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	41
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	40
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	40
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	40
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	40
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	38
Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder	38
Hydrate to keep the amyloid away	37
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	37
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	36
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	36
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	36
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	35
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	35
Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	35
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	35
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	35
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	35
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	34
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	34
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	33
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	33
Incident Dementia After Spontaneous Intracerebral Hemorrhage	33
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	33
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	33
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	33
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	32
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	32
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	32
Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy	32
Attentional Control in Subjective Cognitive Decline	32
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	32
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	31
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	31
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	31
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	30
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	30
α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease	30

FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	30
Association of Amyotrophic Lateral Sclerosis and Alzheimer’s Disease: New Entity or Coincidence? A Case Series	30
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	30
Difficulties with Activities of Daily Living and Receipt of Care Among Older Adults with Cognitive Impairment: Differences Between Those Living Alone and Those Living with Others	30
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	30
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	29
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	29
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	29
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	29
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	28
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	28
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	28
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	28
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	28
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	28
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	27
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	27
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	27
JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model1	27
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	26
A Review of Oxidative Stress Products and Related Genes in Early Alzheimer’s Disease	26
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	26
Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer’s Di	26
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	26
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	26
The Diagnostic Value of a Short Memory Test: The TNI-93	26
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	26
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	26
Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011–2014)	26
Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer’s Disease and Cognitive Function	26
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	26
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	25
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	25
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	25
Phosphorylation and Glycosylation of Amyloid-β Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer’s Disease	25
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	25
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	25
Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer’s Disease	25
Societal Costs of Dementia: 204 Countries, 2000–2019	25
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	25
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	25
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	25
Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study	25
Efficacy of a Virtual Education Program for Family Caregivers of Persons Living with Dementia	24
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	24
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	24
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	24
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	24
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	24
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	24
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	24
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	24
Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study	23
Developing an Image-Based Deep Learning Framework for Automatic Scoring of the Pentagon Drawing Test	23
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	23
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	23
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	23
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	23
The role of carotenoids from red mamey fruit (Pouteria sapota) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET prediction	23
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	23
Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study	23
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	23
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	23
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	23
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	23
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	22
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	22
The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review	22
COVID-19 and Alzheimer’s Disease: What Is the Connection?	22
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	22
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	22
Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study	22
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	22
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	22
Evaluation of early-phase ¹⁸ F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with ¹⁸ F-FDG PE	22
Meaning in life and neurobiomarkers of brain health in the UK Biobank	22
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	22
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	22
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentratio	22
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	22

Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	22
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	21
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	21
Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	21
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	21
Systematic Review on the Role of Lobar Cerebral Microbleeds in Cognition	21
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	21
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function	21
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	21
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	21
A Decade of Decline in Serious Cognitive Problems Among Older Americans: A Population-Based Study of 5.4 Million Respondents	21
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	21
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	21
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	20
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	20
The relationship between postoperative cognitive dysfunction and cerebral small vessel disease: A comprehensive review	20
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	20
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	20
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	20
Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice	20
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	20
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	20
No Influence of Age-Related Hearing Loss on Brain Amyloid-β	20
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	20
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	20
Factors influencing rates of unsupervised assessment of short-term learning in cognitively unimpaired adults	20
Anti-CMV IgG Seropositivity is Associated with Plasma Biomarker Evidence of Amyloid-β Accumulation	20
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	20
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	20
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	20
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	20
Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer’s Disease	20
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	20
Aqueous and Plasma Levels of Phosphorylated Tau 181 in Individuals with Normal Cognition	20
Association of Age with Dual-Task Objective Cognitive Indicators and Gait Parameters in Older Adults	19
Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease	19
Plasma Biomarkers as Predictors of Progression to Dementia in Individuals with Mild Cognitive Impairment	19
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	19
Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis	19
The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study	19
Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer’s Disease	19
Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer’s Disease	19
Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1	19
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid	19
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	19
Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer’s Disease	19
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	19
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment	19
The Association Between Cognition of Obstructive Sleep Apnea Patients and Urinary AD7c-NTP Level: Investigation and Application	18
Digital Biomarkers for the Assessment of Non-Cognitive Symptoms in Patients with Dementia with Lewy Bodies: A Systematic Review	18
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	18
A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies	18
Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging	18
A Longitudinal Study of Functional Unmet Need Among People with Dementia	18
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?	18
Biomarkers and Mindfulness: A Way Forward	18
Toward Pre-Diagnostic Detection of Dementia in Primary Care	18
Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment	18
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers	18
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer’s Disease Pathology	18
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	18
Can Medial Temporal Impairment Be an Imaging Red Flag for Neurodegeneration in Disproportionately Enlarged Subarachnoid Space Hydrocephalus?	18
Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer’s Disease and Argyrophilic Grain Disease	18
Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer’s Disease	18
Prevalence and Safety of COVID-19 Vaccination in Community-Dwelling People with Dementia: Findings from a Tertiary Memory Clinic in Italy	18
Retraction to: Potential Mechanisms Linking Cholesterol to Alzheimer’s Disease-like Pathology in Rabbit Brain, Hippocampal Organotypic Slices, and Skeletal Muscle	18
Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life	18
Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain	18
Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer’s Disease in a Clinical Setting: A REMEMBER Study	18
Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells	18
Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study	18
Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study	18
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	17
Towards characterizing subjective cognitive decline in older adults	17
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians’ Judgements for Person-Centered Care: An Analytic Hierarchy Process Study	17
Assessment of diffusivity along the perivascular space in early- and late-onset Alzheimer's disease	17
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	17
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease	17
Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease	17
Physician Diagnosis and Knowledge of Mild Cognitive Impairment	17
Sex differences in cognitive trajectories and practice effects in a cohort of older Londoners: The role of risk factors	17
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	17
Loneliness, Dementia Status, and Their Association with All-Cause Mortality Among Older US Adults	17
Dementia Knowledge, Attitude toward Dementia, and Confidence in Dementia Care: Impact of a Dementia Training on German Nursing Students	17
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease	17
Hippocampal-Subregion Mechanisms of Repetitive Transcranial Magnetic Stimulation Causally Associated with Amelioration of Episodic Memory in Amnestic Mild Cognitive Impairment	17
Protocol for a Mixed-Methods Process Evaluation of BetterBrains: A Person-Centered Online Intervention to Delay Cognitive Decline in Adults at Risk of Dementia	17
Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration	17
Disrupted Excitation-Inhibition Balance in Cognitively Normal Individuals at Risk of Alzheimer’s Disease	17
Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia	17
Association of Plastic Exposure with Cognitive Function Among Chinese Older Adults	17
Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-base	17
New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity	17
Biomarkers and Risk Assessment of Alzheimer’s Disease in Low- and Middle-Income Countries	17
Blood Tests for Alzheimer’s Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance	17